United States· US:0169-7905_4d658384-07d9-471f-8b15-16b8cec36765
REBINYN
A medicinal product, registered in United States by Novo Nordisk.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Manufacturer
- Novo Nordisk
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1101697905011 KIT in 1 KIT (0169-7905-01) * 4 mL in 1 VIAL, GLASS (0169-7955-90) * 4 mL in 1 SYRINGE, GLASS (0169-7009-98) * 4 mL in 1 VIAL, GLASS (0169-7955-11)
- ndc1101697905971 KIT in 1 KIT (0169-7905-97) * 4 mL in 1 VIAL, GLASS (0169-7955-90) * 4 mL in 1 SYRINGE, GLASS (0169-7009-98) * 4 mL in 1 VIAL, GLASS (0169-7955-11)
- ndc110169-7905-01
- ndc110169-7905-97
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c66146ba-1790-4747-91cf-6f6f4194653e GET /v1/drugs/c66146ba-1790-4747-91cf-6f6f4194653e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": null,
"source": "ndc",
"strength": null,
"substance": null,
"productndc": "0169-7905",
"dosage_form": "KIT",
"dea_schedule": null,
"strength_unit": null,
"application_number": "BLA125611",
"marketing_category": "BLA"
}See everything about REBINYN.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.